Literature DB >> 19332577

Financial incentives for patients in the treatment of psychosis.

G Szmukler1.   

Abstract

Poor medication adherence in patients with a psychosis is associated with relapse. It has been proposed that outcomes might be improved by using financial incentives for treatment adherence (FITA). However, a strong moral intuition against this practice has been found. This paper examines the ethics of FITA. Three arguments are presented, which if accepted would severely restrict or even prohibit the practice. These are based on (1) "incommensurable values", where FITA denigrates an aspect of "respect for the person", (2) "exploitation", where unfair advantage is taken of the patient, and (3) "fairness", where it is difficult to draw a line between those who should and should not be offered payment. A number of practical impediments are also considered.

Entities:  

Mesh:

Year:  2009        PMID: 19332577     DOI: 10.1136/jme.2008.027151

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  6 in total

1.  Reflections on the development of health inequalities policy in England.

Authors:  Adam Oliver
Journal:  Health Care Anal       Date:  2010-12

2.  Financial incentives to encourage healthy behaviour: an analysis of U.K. media coverage.

Authors:  Hannah Parke; Richard Ashcroft; Rebecca Brown; Theresa M Marteau; Clive Seale
Journal:  Health Expect       Date:  2011-07-20       Impact factor: 3.377

3.  Can incentives improve antipsychotic adherence in major mental illness? A mixed-methods systematic review.

Authors:  Nathan Hodson; Madiha Majid; Ivo Vlaev; Swaran Preet Singh
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

4.  Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: a focus group study.

Authors:  Stefan Priebe; Julia Sinclair; Alexandra Burton; Stamatina Marougka; John Larsen; Mike Firn; Richard Ashcroft
Journal:  J Med Ethics       Date:  2010-06-27       Impact factor: 2.903

5.  Offering financial incentives to increase adherence to antipsychotic medication: the clinician experience.

Authors:  Elizabeth Highton-Williamson; Kirsten Barnicot; Tarrannum Kareem; Stefan Priebe
Journal:  J Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.153

6.  Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.

Authors:  Ernst L Noordraven; Maartje H N Schermer; Peter Blanken; Cornelis L Mulder; André I Wierdsma
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.